Deanna Harshbarger, a leader in US HealthTech, is the CEO of Cala Health, a bioelectronic medicine company transforming care for chronic diseases. Previously Co-President and Chief Product Officer, she brings 20+ years’ experience in medical devices, including roles at Medtronic and Boston Scientific. Harshbarger’s expertise spans healthcare strategy, product management, and marketing. Cala Health’s wearable neuromodulation therapies merge neuroscience and tech, offering individualized peripheral nerve stimulation, initially for essential tremor, and with new therapies in development.
666 3rd Ave, 6th Floor, New York, NY 10017